Corvus Pharmaceuticals (CRVS)
(Real Time Quote from BATS)
$2.25 USD
-0.04 (-1.75%)
Updated May 20, 2024 03:28 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
Brokerage Reports
Corvus Pharmaceuticals, Inc. [CRVS]
Reports for Purchase
Showing records 121 - 140 ( 154 total )
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology - ASCO Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Corvus'' ASCO Update. We''re Getting Closer - Next Stop, SITC
Provider: Roth Capital Partners, Inc.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
First Look at CPI-006; Evidence of Broader Immune Effects for CD73
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - An Ode to the Tumor Microenvironment
Provider: Roth Capital Partners, Inc.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a Buy rating and a $6 PT
Provider: Roth Capital Partners, Inc.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology- ASCO Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q4 Financials; ITK inhibitor CPI-818 Moves into Clinic
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
SITC 2018 Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; Clinical Update at SITC for CPI-444
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology - ESMO 2018 Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D